Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David Tebar-García"'
Autor:
María del Mar Noblejas-López, Cristina Nieto-Jiménez, Eva M. Galán-Moya, David Tebar-García, Juan Carlos Montero, Atanasio Pandiella, Miguel Burgos, Alberto Ocaña
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-12 (2021)
Abstract Background Although the anti-HER2 antibody trastuzumab augments patient survival in HER2+ breast cancer, a relevant number of patients progress to this treatment. In this context, novel drug combinations are needed to increase its antitumor
Externí odkaz:
https://doaj.org/article/27735656da444e08a86d58977135ef31
Autor:
David Tebar-García, Eva María Galán-Moya, Cristina Nieto-Jiménez, Juan Carlos Montero, Atanasio Pandiella, Alberto Ocaña, María Del Mar Noblejas-López, Miguel Burgos
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-12 (2021)
Journal of Experimental & Clinical Cancer Research : CR
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Experimental & Clinical Cancer Research : CR
Digital.CSIC. Repositorio Institucional del CSIC
instname
© The Author(s).
[Background]: Although the anti-HER2 antibody trastuzumab augments patient survival in HER2+ breast cancer, a relevant number of patients progress to this treatment. In this context, novel drug combinations are needed to increa
[Background]: Although the anti-HER2 antibody trastuzumab augments patient survival in HER2+ breast cancer, a relevant number of patients progress to this treatment. In this context, novel drug combinations are needed to increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7bd4779fc91950a331a1fc48ae69b94
http://hdl.handle.net/10261/261902
http://hdl.handle.net/10261/261902
Autor:
Silvia Llorens, Natalia Moratalla-López, Eva María Galán-Moya, Eduardo Nava, David Tebar-García, Raquel Lopez-Rosa, Lesgui Alviz, Gonzalo L. Alonso
Publikováno v:
Nutrients
Volume 13
Issue 3
Nutrients, Vol 13, Iss 1032, p 1032 (2021)
RUIdeRA. Repositorio Institucional de la UCLM
instname
RUIdeRA: Repositorio Institucional de la UCLM
Universidad de Castilla-La Mancha
Volume 13
Issue 3
Nutrients, Vol 13, Iss 1032, p 1032 (2021)
RUIdeRA. Repositorio Institucional de la UCLM
instname
RUIdeRA: Repositorio Institucional de la UCLM
Universidad de Castilla-La Mancha
In diabetes mellitus type 2 (DM2), developed obesity is referred to as diabesity. Implementation of a healthy diet, such as the Mediterranean, prevents diabesity. Saffron is frequently used in this diet because of its bioactive components, such as cr
Autor:
Alviz, Lesgui, Tebar-García, David, Lopez-Rosa, Raquel, Galan-Moya, Eva M., Moratalla-López, Natalia, Alonso, Gonzalo L., Nava, Eduardo, Llorens, Sílvia, Jeppesen, Per
Publikováno v:
Nutrients; Mar2021, Vol. 13 Issue 3, p1032, 1p